Here are the latest stories being discussed in biopharma today:
Biotech Supplier Faces Pentagon Scrutiny amid Alleged Ties to Chinese Military
American legislators are calling for the addition of Chinese genomics giant BGI’s US subsidiaries to the Pentagon’s watch list, over allegations that these firms collaborate with the Chinese military. Critics argue that such companies should face restrictions on their dealings with US biopharmas.
Astellas Executive Fears EU Pharma Reforms Could Deter Investment
Claus Zieler, a top executive at Astellas and industry group leader, says upcoming legislative reforms for the European pharma sector may make the continent less attractive for R&D investment. Among the changes Zieler opposes is a decrease in the data protection period, reducing it by six months.
US Prepared to Respond to Avian Flu, declares CBER’s Marks
Peter Marks, the FDA’s head of Biologics, insists the US’s stockpiles of H5N1 vaccines are sufficient for tackling any potential avian flu outbreaks. This announcement comes following a recent reported case of avian flu in a human in Texas.
Liquidia Triumphs over United Therapeutics in Patent Dispute over PAH Drug
Pharma company Liquidia has won two significant court cases against United Therapeutics, potentially clearing the way for their version of a pulmonary arterial hypertension (PAH) drug to enter the $1.2 billion market.
Eiger Biopharmaceuticals to Cease Operations Following Bankruptcy Filing
Eiger Biopharmaceuticals has filed for Chapter 11 bankruptcy and confirmed plans to wind down operations. Sentynl Therapeutics could potentially purchase the rights to Zokinvy, Eiger’s approved treatment for Hutchinson-Gilford progeria syndrome, for up to $26 million.
Gilead Promotes Sexual Health through Ballroom Dancing Workshop
Gilead is hosting a dance event in New York to engage with the LGBTQ+ ballroom community and promote awareness about sexual health and HIV prevention. Hosted by actor and dance aficionado Jason A. Rodriguez, the occasion aims to empower community members and prioritize their sexual health.
